Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04725747 · ClinicalTrials.gov registry record
Exploring Sedation Types During Cataract Surgery
A clinical trial, sponsored by Vance Thompson Vision.
- Completed
- Registry status
- 1,111
- Enrollment target
NCT04725747 is a clinical trial that has completed, run by Vance Thompson Vision. The registered enrollment target is 1,111 participants.
The verdict
NCT04725747 has completed, sponsored by Vance Thompson Vision.
- COMPLETED
- Registry status
- 1,111 participants
- Enrollment target
Study Summary
This study is designed to explore the sedative and analgesic effectiveness of the Midazolam/Ketamine melt compared to IV sedation in subjects undergoing intraocular surgery.
Interventions
- DRUG Intravenous Sedatives with or Without Analgesia
- DRUG Midazolam/Ketamine HCl 3mg-50mg sublingual
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,111 participants |
| Start Date | 2021-01-25 |
| Est. Completion | 2021-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04725747
The ClinicalTrials.gov registry entry for NCT04725747 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,111 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vance Thompson Vision, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Intravenous Sedatives with or Without Analgesia is the first listed.
NCT04725747 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04725747 about?
NCT04725747 is a clinical study titled "Exploring Sedation Types During Cataract Surgery". This study is designed to explore the sedative and analgesic effectiveness of the Midazolam/Ketamine melt compared to IV sedation in subjects undergoing intraocular surgery.
What is the current status of trial NCT04725747?
This trial is currently completed. The enrollment target is 1,111 participants. The study started on 2021-01-25. Estimated completion is 2021-06-30.
What interventions are being tested in trial NCT04725747?
The interventions under investigation include: Intravenous Sedatives with or Without Analgesia (DRUG), Midazolam/Ketamine HCl 3mg-50mg sublingual (DRUG).
Who is sponsoring clinical trial NCT04725747?
This trial is sponsored by Vance Thompson Vision, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.